October 28, 2008--CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ: IVGN) today announced that its shareholders have voted to approve the company's proposed merger with Applied ...

Invitrogen Corporation (NASDAQ: IVGN) and Applera Corporation today announced that their Boards of Directors have approved a definitive merger agreement, under which Invitrogen will acquire all of the ...

From a solo flight around the world in his single-engine plane to starting a foundation that protects endangered coral reefs, Lyle Turner has seldom sat still in the decade since he retired from ...

President and COO of Applied Biosystems Answers GEN’s Questions about the Merger I recently attended a press event where the joint venture between Applied Biosystems (AB) /MDS Analytical Technologies ...

In 1987, three local researchers gathered in an Encinitas garage with an idea that, 26 years later, is worth $13.6 billion. The garage belonged to Lyle Turner, who got together with partners Joe ...

Accurate and efficient data analysis of protein targets is an integral part of the gel and western blot imaging workflow. The Invitrogen iBright Analysis Software is an optimized software application ...

Invitrogen (www.invitrogen.com), supplier of reagents and tools for gene and protein research for 20 years, is expanding its product lines and moving toward cell biology. In the past few years, ...

The company created by the merger, expected to close this fall pending regulatory and shareholder approval, will retain the Applied Biosystems name while operating out of Invitrogen's Carlsbad, CA ...

Invitrogen Corp., a maker of chemical kits used to analyze and clone genes, agreed to buy BioReliance Corp. for $430 million to expand its production capabilities for biotechnology customers.

Invitrogen Corporation has announced the acquisitions of Quantum Dot Corporation and the BioPixels® business unit of BioCrystal, Ltd. and the early closing of the Biosource International, Inc.

Invitrogen Corporation and Sentigen Holding Corp. have announced that they have entered into a definitive merger agreement under which Invitrogen will acquire New Jersey-based Sentigen in a cash ...